CLINICAL TRIAL SOLUTIONS

Full Service: Phase I CRO

Our Phase I CRO team leverages robust early phase experience, industry-best biometrics timelines, and strong site partnerships to help clients confidently and quickly pursue study success.

How can we support you?

Explore our Phase I CRO Services

PharPoint works diligently to help clients plan, manage, and analyze effective Phase I clinical trials. Our team has supported over 400 Phase 1 clinical trials and is a trusted partner for sponsors looking for full service Phase I CRO support.

Site Feasibility

Our analysis and insight can help sponsors effortlessly identify effective sites that can meet study goals.

Clinical Operations

Our team works to ensure study excellence and transparent collaboration between CRO, site, and Sponsor.

Clinical Data Management

Work with a clinical data management team that prioritizes your data from day one.

Biostatistics & Statistical Programming

Our consultative approach to biostatistics services includes a level of responsiveness, support, and proactiveness that is unmatched within the industry.

THE PHARPOINT DIFFERENCE

Helping sponsors meet their Phase I study goals

AN EXPERIENCED TEAM

For Phase I Success

PharPoint aligns sponsors with teammates that have the right knowledge and expereince to overcome potential study challenges. Our Phase I CRO experience includes supporting first-in-human studies as well both studies that use normal healthy volunteers and patient populations.

IDENTIFY THE RIGHT SITES

with PharPoint’s Site Agnostic Approach

Finding the right sites to support your trial is a vital step in ensuring your study will enroll on time. Rather than pushing clients toward owned units that may not fit study needs, PharPoint uses a site-agnostic approach.

We prioritize identifying and selecting the best-possible site parter for your unique study details and requirements. This process evaluates factors such as availability, competing studies, patient access, and unique capabilities and experience – ultimately matching clients with site partners that will help them meet study goals.

EXPEDITE SITE ACTIVATIONS

with Our Pre-Qualified Network

PharPoint’s expanding site relationships includes a number of pre-qualified US sites with CDAs in place to expedite site activation. These sites have strong clinical trial capabilities that are matched to specific study needs as part of our site-agnostic approach.

GET RESULTS FASTER

with PharPoint’s Industry-Best Biometrics Timelines

At every step, PharPoint’s standard biometrics CRO timelines are industry-best. Throughout your study, clean data are soft locked, reducing the number of subjects needing to be locked following Last Participant, Last Visit (LPLV) and decreasing the timeline to database lock to only 5 days after final Source Document Verification (SDV).